AR099137A2 - Formulación para compresión directa y proceso - Google Patents

Formulación para compresión directa y proceso

Info

Publication number
AR099137A2
AR099137A2 ARP150100149A ARP150100149A AR099137A2 AR 099137 A2 AR099137 A2 AR 099137A2 AR P150100149 A ARP150100149 A AR P150100149A AR P150100149 A ARP150100149 A AR P150100149A AR 099137 A2 AR099137 A2 AR 099137A2
Authority
AR
Argentina
Prior art keywords
percent
dry weight
pharmaceutically acceptable
weight
weight basis
Prior art date
Application number
ARP150100149A
Other languages
English (en)
Spanish (es)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39962907&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR099137(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR099137A2 publication Critical patent/AR099137A2/es

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP150100149A 2004-01-20 2015-01-20 Formulación para compresión directa y proceso AR099137A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53770604P 2004-01-20 2004-01-20

Publications (1)

Publication Number Publication Date
AR099137A2 true AR099137A2 (es) 2016-06-29

Family

ID=39962907

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150100149A AR099137A2 (es) 2004-01-20 2015-01-20 Formulación para compresión directa y proceso

Country Status (4)

Country Link
CN (2) CN101262851A (zh)
AR (1) AR099137A2 (zh)
TN (1) TNSN06223A1 (zh)
ZA (1) ZA200605513B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104856970B (zh) * 2015-06-23 2017-08-25 张磊 一种治疗ⅱ型糖尿病的维格列汀片剂
CN105233300B (zh) * 2015-11-05 2019-10-25 北京泰德制药股份有限公司 一种稳定的维格列汀组合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3131402A1 (de) * 1981-08-07 1983-02-24 Kilian & Co GmbH, 5000 Köln Verfahren und tablettenpresse zum aufeinanderfolgenden herstellen einer vielzahl von tabletten mit gleichem gewicht
DE19823831A1 (de) * 1998-05-28 1999-12-02 Probiodrug Ges Fuer Arzneim Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
FR2822826B1 (fr) * 2001-03-28 2003-05-09 Servier Lab Nouveaux derives sulfonyles d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2824825B1 (fr) * 2001-05-15 2005-05-06 Servier Lab Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1465605A1 (en) * 2002-01-11 2004-10-13 Athpharma Limited Pravastatin pharmaceutical formulations and methods of their use
JP2003327532A (ja) * 2002-05-10 2003-11-19 Takeda Chem Ind Ltd ペプチダーゼ阻害剤

Also Published As

Publication number Publication date
CN101618216A (zh) 2010-01-06
ZA200605513B (en) 2007-11-28
CN101618216B (zh) 2012-01-04
CN101262851A (zh) 2008-09-10
TNSN06223A1 (en) 2007-12-03

Similar Documents

Publication Publication Date Title
AR049000A1 (es) Formulacion para compresion directa y proceso para la preparacion de una tableta directamente comprimida
CO5640076A2 (es) Composicion farmaceutica que comprende un inhibidor de ibat para el tratamiento o profilaxis del estreñimiento
ES2525410T3 (es) Composiciones y métodos para el tratamiento de enfermedades hiperproliferativas dérmicas
AR056291A1 (es) Composiciones farmaceuticas para el tratamiento de la trombosis
GT200500309A (es) Derivados de sulfonilbencilimidazol
CL2008003298A1 (es) Forma de dosificacion oral solida que comprende a) un compuesto de accion doble en concentracion entre 4 y 90%, b) un excipiente farmaceuticamente aceptable; proceso de preparación; uso en el tratamiento de enfermedades cardiovasculares y/o renales.
CR7432A (es) Amidas sustituidas activas del receptor de canabinoide-1
BRPI0616694B8 (pt) processo para preparar comprimido farmacêutico com 80 e 96% em peso com base no peso seco de vildagliptina e metformina ou seus sais farmaceuticamente aceitáveis
HRP20090471T1 (en) Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
GT200600157A (es) Asociacion entre la ferroquina y un derivado de artemisinina para el tratamiento del paludismo
BRPI0616077B8 (pt) composição farmacêutica formulada em uma dose única, kit, artigo de manufatura, uso da composição farmacêutica e uso de um ou mais compostos antidiabéticos
PE20031045A1 (es) Tableta que contiene altas concentraciones de imatinib
ECSP066753A (es) Antagonistas del receptor de quimiocina
PA8586501A1 (es) Tabletas dispersables que comprenden un derivado de acido benzoico
CO6331425A2 (es) Composiciones que comprenden n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)6-metoxifenil)-1-(2,3-dihidroxiproxipropil)ciclopropan-1-sulfamida
PA8562201A1 (es) Formulaciones de acitromicina directamente compresibles
ECSP088379A (es) Tabletas dispersables que comprenden deferasirox
EA201201496A1 (ru) Способ ингибирования интегразы вич, способ улучшения фармакокинетики 6-(3-хлор-2-фторбензил)-1-[(2s)-1-гидрокси-3-метилбутан-2-ил]-7-метокси-4-оксо-1,4-дигидрохинолин-3-карбоновой кислоты (варианты), набор, фармацевтическая композиция (варианты) и антиретровирусный агент (варианты)
PE20040104A1 (es) Composicion farmaceutica que tiene una distribucion y potencia uniforme de farmaco
PE20110431A1 (es) Etexilato de dabigatran o una sal del mismo
WO2007005990A3 (en) Cytoprotective thereapeutic agents for the prevention of reperfusion injury following ischemic stroke
DOP2012000050A (es) Nuevas composiciones de 1-[2-(2,4-dimetil-fenilsulfanil)-fenil] piperazina
PE20110432A1 (es) Etexilato de dabigatran o una sal del mismo
PE20110706A1 (es) Uso de dronedarona para la preparacion de un medicamento para la prevencion de ictus o ataque isquemico transitorio
EA201101231A1 (ru) Способы предотвращения или снижения риска смертности

Legal Events

Date Code Title Description
FC Refusal